Background:
In many high HIV prevalence settings, delivery of pre-exposure prophylaxis (PrEP) in public health facilities is challenged by understaffing, long wait times, and stigma. Expanding PrEP delivery to private pharmacies may help mitigate these barriers. To assess whether current PrEP users would choose to refill their PrEP prescription at a private pharmacy if given the option, we pilot-tested such a model in Kenya.
Methods:
At two public health facilities in Kiambu County, we recruited adult (> 18 years) clients newly initiating PrEP. Once enrolled, clients were given the option to refill PrEP at a public health facility (for free) or at one of three nearby private pharmacies (for a fee of 300 Kenyan Shillings, or ~$2.50 US Dollars). Pharmacy providers at pilot pharmacies were trained on PrEP delivery, including how to counsel on HIV risk and PrEP adherence, assess medical safety, complete HIV testing, and refill prescriptions. At enrollment, we asked clients their preferred location for refilling PrEP. We then followed clients for up to seven months and assessed whether and where clients chose to refill their PrEP prescription.
Results:
From November 2020 to October 2021, we screened 125 clients and enrolled 106. Among enrolled clients, the median age was 31 (IQR 26-38), 59% (n=63) were female, 67% (n=71) were married, and 49% (n=52) were in an HIV serodifferent relationship. At enrollment, clients’ preferred refill location was split between public health facilities (55%, n=58) and private pharmacies (45%, n=48). Over 292 total client-months of observation (median: 1 months per client, IQR 1-4), 42% (n=44) of clients refilled PrEP at least once, and only 3 (3%) clients refilled PrEP at a pilot pharmacy. There was no difference in PrEP continuation (p < 0.05) based on clients’ stated preference for PrEP refill location.
Conclusions:
Few clients who initiated PrEP at a public health facility in this pilot opted to refill their PrEP prescription at a private pharmacy, despite over half stating a preference for pharmacy-based refills. This data suggests that once PrEP clients in Kenya have overcome barriers to initiate PrEP at a facility, continuation at this location may be easier than at a new location. Additional research is needed to understand drivers of PrEP refill location choice (e.g., cost, trust in service provider) and test implementation strategies (e.g., vouchers) that might enable clients to select their preferred refill location.